Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.
Cheng ChengDi WangMingchen YuYou ZhaiChangqing PanBo LiangJiazheng ZhangChen WangYiyun YinLianwang LiFan WuZhongfang ShiXing FanXing LiuZhiliang WangZheng ZhaoGuanzhang LiTao JiangWei Zhangnull nullPublished in: Neurosurgery (2023)
Identification and assessment of histone H3 status in clinical practice might help improve prognostic prediction and develop therapeutic strategies for these patient subgroups.